Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos Genomics Partners with Bayer on Asthma Gene Expression Research

NEW YORK, June 13 – Galapagos Genomics is collaborating with Bayer Yakuhin of Japan to identify and evaluate the function of proteins associated with asthma, the company announced Wednesday.

Galapagos, of Mechelen, Belgium, will construct recombinant adenoviruses containing asthma-associated human genes supplied by  Bayer Yakuhin, a subsidiary of German pharmaceutical giant Bayer. Bayer Yakuhin will then use the viruses to introduce the genes into human cells, in order to discern how the proteins encoded by these genes work at a cellular level.

The parties did not disclose the financial terms of the collaboration.

Galapagos, a privately held company, has developed a PhenoSelect expression platform technology, in which it has arrayed adenoviruses with human genes. The company will use this proprietary platform in its collaboration.

“This is Galapagos’ first collaboration with a top-tier pharmaceutical company and it is therefore an important milestone for the company,” Galapagos CEO Onno van de Stolpe said in a statement. “This collaboration is an endorsement of our platform as an important tool in the rapid identification and validation of drug targets out of large gene collections.”

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.